News
-
-
-
COMMUNIQUÉ DE PRESSE
ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
ONWARD Medical reports strong first half 2026 results with robust revenue growth and pipeline progress. Financial highlights include EUR 4.2M revenue and EUR 81.5M cash balance. CEO Dave Marver highlights successful ARC-EX System launch -
-
-
COMMUNIQUÉ DE PRESSE
ONWARD Medical Publishes Closing of Bookbuild Offering
ONWARD Medical N.V. announces closing of EUR 40.6M Private Placement with institutional investors, new shares listed on Euronext. Company pioneering neurotechnology therapies for spinal cord injuries and movement disabilities -
-
-
-
